Cargando…
Insights from Transcriptomics: CD163(+) Profibrotic Lung Macrophages in COVID-19
Coronavirus disease (COVID-19) begins with upper airway symptoms but proceeds in a significant proportion of patients to life-threatening infection of the lower respiratory tract, where an exuberant inflammatory response, edema, and adverse parenchymal remodeling impair gas exchange. Respiratory fai...
Autor principal: | Bhattacharya, Mallar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651197/ https://www.ncbi.nlm.nih.gov/pubmed/35675555 http://dx.doi.org/10.1165/rcmb.2022-0107TR |
Ejemplares similares
-
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
por: Aran, Dvir, et al.
Publicado: (2019) -
Collagen‐Specific HSP47
(+) Myofibroblasts and CD163
(+) Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS‐CoV‐2 Infections
por: Puzyrenko, Andrii, et al.
Publicado: (2023) -
Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020) -
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
por: Graversen, Jonas Heilskov, et al.
Publicado: (2015) -
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020)